NCT04661514View on ClinicalTrials.gov

Evaluation of Psilocybin in Anorexia Nervosa: Safety and Efficacy

PHASE2CompletedINTERVENTIONAL

Enrollment

16

Participants

Timeline

Start Date

May 1, 2021

Primary Completion Date

March 10, 2022

Study Completion Date

June 10, 2022

Conditions

Anorexia Nervosa

Interventions

DRUG

Psilocybin

Psilocybin-assisted psychotherapy

Trial Locations (1)

92037

Altman Clinical and Translational Research Institute, La Jolla

Sponsors

Collaborators (1)

COMPASS Pathways

All Listed Sponsors

collaborator

COMPASS Pathways

INDUSTRY

lead

University of California, San Diego

OTHER